336 related articles for article (PubMed ID: 18728184)
1. Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids.
Agbaga MP; Brush RS; Mandal MN; Henry K; Elliott MH; Anderson RE
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12843-8. PubMed ID: 18728184
[TBL] [Abstract][Full Text] [Related]
2. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.
Barabas P; Liu A; Xing W; Chen CK; Tong Z; Watt CB; Jones BW; Bernstein PS; Križaj D
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5181-6. PubMed ID: 23479632
[TBL] [Abstract][Full Text] [Related]
3. Biosynthesis of very long-chain polyunsaturated fatty acids in hepatocytes expressing ELOVL4.
Agbaga MP; Logan S; Brush RS; Anderson RE
Adv Exp Med Biol; 2014; 801():631-6. PubMed ID: 24664752
[TBL] [Abstract][Full Text] [Related]
4. ELOVL4 protein preferentially elongates 20:5n3 to very long chain PUFAs over 20:4n6 and 22:6n3.
Yu M; Benham A; Logan S; Brush RS; Mandal MNA; Anderson RE; Agbaga MP
J Lipid Res; 2012 Mar; 53(3):494-504. PubMed ID: 22158834
[TBL] [Abstract][Full Text] [Related]
5. ELOVL4 Mutations That Cause Spinocerebellar Ataxia-34 Differentially Alter Very Long Chain Fatty Acid Biosynthesis.
Gyening YK; Chauhan NK; Tytanic M; Ea V; Brush RS; Agbaga MP
J Lipid Res; 2023 Jan; 64(1):100317. PubMed ID: 36464075
[TBL] [Abstract][Full Text] [Related]
6. Current Progress in Deciphering Importance of VLC-PUFA in the Retina.
Bennett LD; Anderson RE
Adv Exp Med Biol; 2016; 854():145-51. PubMed ID: 26427405
[TBL] [Abstract][Full Text] [Related]
7. A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report.
Gyening YK; Boris K; Cyril M; Brush RS; Nassogne MC; Agbaga MP
Acta Neuropathol Commun; 2023 Aug; 11(1):131. PubMed ID: 37568198
[TBL] [Abstract][Full Text] [Related]
8. Effect of reduced retinal VLC-PUFA on rod and cone photoreceptors.
Bennett LD; Brush RS; Chan M; Lydic TA; Reese K; Reid GE; Busik JV; Elliott MH; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3150-7. PubMed ID: 24722693
[TBL] [Abstract][Full Text] [Related]
9. Epidermal expression of an Elovl4 transgene rescues neonatal lethality of homozygous Stargardt disease-3 mice.
McMahon A; Butovich IA; Kedzierski W
J Lipid Res; 2011 Jun; 52(6):1128-1138. PubMed ID: 21429867
[TBL] [Abstract][Full Text] [Related]
10. Elovl4 5-bp deletion does not accelerate cone photoreceptor degeneration in an all-cone mouse.
Schori C; Agbaga MP; Brush RS; Ayyagari R; Grimm C; Samardzija M
PLoS One; 2018; 13(1):e0190514. PubMed ID: 29293603
[TBL] [Abstract][Full Text] [Related]
11. The Elovl4 Spinocerebellar Ataxia-34 Mutation 736T>G (p.W246G) Impairs Retinal Function in the Absence of Photoreceptor Degeneration.
Agbaga MP; Stiles MA; Brush RS; Sullivan MT; Machalinski A; Jones KL; Anderson RE; Sherry DM
Mol Neurobiol; 2020 Nov; 57(11):4735-4753. PubMed ID: 32780351
[TBL] [Abstract][Full Text] [Related]
12. Essential role of ELOVL4 protein in very long chain fatty acid synthesis and retinal function.
Harkewicz R; Du H; Tong Z; Alkuraya H; Bedell M; Sun W; Wang X; Hsu YH; Esteve-Rudd J; Hughes G; Su Z; Zhang M; Lopes VS; Molday RS; Williams DS; Dennis EA; Zhang K
J Biol Chem; 2012 Mar; 287(14):11469-80. PubMed ID: 22199362
[TBL] [Abstract][Full Text] [Related]
13. Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.
Logan S; Agbaga MP; Chan MD; Kabir N; Mandal NA; Brush RS; Anderson RE
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5446-51. PubMed ID: 23509295
[TBL] [Abstract][Full Text] [Related]
14. Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks.
Agbaga MP; Tam BM; Wong JS; Yang LL; Anderson RE; Moritz OL
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3669-80. PubMed ID: 24833735
[TBL] [Abstract][Full Text] [Related]
15. DHA does not protect ELOVL4 transgenic mice from retinal degeneration.
Li F; Marchette LD; Brush RS; Elliott MH; Le YZ; Henry KA; Anderson AG; Zhao C; Sun X; Zhang K; Anderson RE
Mol Vis; 2009 Jun; 15():1185-93. PubMed ID: 19536303
[TBL] [Abstract][Full Text] [Related]
16. Hetero-oligomeric interactions of an ELOVL4 mutant protein: implications in the molecular mechanism of Stargardt-3 macular dystrophy.
Okuda A; Naganuma T; Ohno Y; Abe K; Yamagata M; Igarashi Y; Kihara A
Mol Vis; 2010 Nov; 16():2438-45. PubMed ID: 21139992
[TBL] [Abstract][Full Text] [Related]
17. Examination of VLC-PUFA-deficient photoreceptor terminals.
Bennett LD; Hopiavuori BR; Brush RS; Chan M; Van Hook MJ; Thoreson WB; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(7):4063-72. PubMed ID: 24764063
[TBL] [Abstract][Full Text] [Related]
18. Mouse Models of Stargardt 3 Dominant Macular Degeneration.
Barabas P; Gorusupudi A; Bernstein PS; Krizaj D
Adv Exp Med Biol; 2016; 854():137-43. PubMed ID: 26427404
[TBL] [Abstract][Full Text] [Related]
19. Different Mutations in ELOVL4 Affect Very Long Chain Fatty Acid Biosynthesis to Cause Variable Neurological Disorders in Humans.
Agbaga MP
Adv Exp Med Biol; 2016; 854():129-35. PubMed ID: 26427403
[TBL] [Abstract][Full Text] [Related]
20. Homozygous Expression of Mutant ELOVL4 Leads to Seizures and Death in a Novel Animal Model of Very Long-Chain Fatty Acid Deficiency.
Hopiavuori BR; Deák F; Wilkerson JL; Brush RS; Rocha-Hopiavuori NA; Hopiavuori AR; Ozan KG; Sullivan MT; Wren JD; Georgescu C; Szweda L; Awasthi V; Towner R; Sherry DM; Anderson RE; Agbaga MP
Mol Neurobiol; 2018 Feb; 55(2):1795-1813. PubMed ID: 29168048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
